The relationship with companies and their employees is changing. So are expectations on corporations to respond to the social/political issues that we are facing today. What is the role of the CEO and CHRO as companies grapple with the communication challenges brought on in this environment? Where are the opportunities to take a stand? What are the drawbacks of doing so? What are the drawbacks of silence? What are the implications globally inside and outside the corporate? How do we do this successfully? What are the important issues to consider?
Join us virtually on Wednesday, January 19th from 9:00 am – 11:00 am with a panel of experts who will guide us through an effective decision-making process for dealing with social Issues effectively and with impact.
Co-founder/DEI Practice Leader,
Jim Rottman is the founding Practice Leader of AccelPeople. Recognized on the Economist’s Global Diversity List as one of the top 50 global diversity and inclusion professionals, Jim actively works with CEOs and HR leaders to build high-performance management teams and corporate cultures in biotech, healthcare, and advanced technology companies. Innovation is Jim’s driving passion, with over 20 years of experience in the corporate and nonprofit world as a senior executive, board member, and entrepreneur. Jim was the first Global Head of Diversity and Inclusion for Roche Pharma, preceded by his role as People and Culture Director at Genentech. At American Express, Jim was promoted to VP of HR and Workplace Innovation following his prior positions there in technology and finance. He continues to be anchored in an entrepreneurial spirit and mindset whether working with small, medium or large companies. Jim has been invited by the White House and United Nations to provide insight and best practices on people leadership, and he is a Founding member for Healthcare Business Women’s Association Gender Parity Collaborative. He currently serves as the Board President for the Ceres Project. Recently, Jim has begun learning the craft of hand forging chef’s knives.
Chief Human Resources and
Communications Officer, Corcept Therapeutics
Ms. Flood joined Corcept as Chief Human Resources and Communications Officer in July 2021. She brings nearly 25 years of experience in communications, team development and culture building within the biopharmaceutical industry. Ms. Flood previously spent 21 years at Gilead Sciences, most recently as Senior Vice President, Public Affairs, where she led a global team responsible for corporate brand, employee communications, product public relations, advocacy and philanthropy. While at Gilead she also led company-wide efforts to expand professional development opportunities for women, a targeted team mentoring and development initiative, and multiple programs focused on diversity, equity and inclusion. Prior to joining Gilead, Ms. Flood worked in healthcare public relations in New York, relocating to San Francisco to help establish her firm’s West Coast operations. She is a member of the board of Point Source Youth, a national non-profit dedicated to ending youth homelessness. She is a graduate of Johns Hopkins University.
SVP of HR, OD & Learning at Adverum
Biotechnologies VP, Investor Relations
Dena House is Adverum’s senior vice president of human resources, organizational development and learning, and joined the Company in July 2019. Ms. House brings 25 years of experience, including global human resource (HR) leadership and a background in industrial and organizational psychology, organization, leadership & employee development, and culture enhancement initiatives. Most recently, Ms. House was on the Lead Team for Myriad Women’s Health at Myriad Genetics, in the position of senior director, HR, overseeing the Bay Area subsidiary’s HR function, company integration, and employee engagement. Previously, Ms. House worked for a decade at Nikon Precision as the HR director, heading up the HR function and working on organization development globally for Nikon Corporation. Earlier in her career, she worked for Applied Materials, Inc. for over twelve years in positions of increasing responsibilities within the HR function and implementing HR initiatives, and leadership development across various global regions. Ms. House earned a B.A. in Psychology from the University of San Francisco and an M.S. in Industrial/Organizational Psychology from San Jose State University.
Vice President, Head of Corporate Strategy
and External Affairs & Engagement at Adverum Biotechnologies, Inc.
Anand Reddi is Adverum’s vice president, head of corporate strategy and external affairs & engagement. He is responsible for leading Adverum’s corporate strategy, investor relations, corporate communications, patient advocacy, public affairs, global market access and government affairs & policy. He also serves as Chief of Staff.
Mr. Reddi joins Adverum from Gilead Sciences Inc., where he most recently served as head of digital innovation, customer engagement, global commercial strategy and operations. In this role, he led the design, implementation, and launch of PrEP Hub™, a direct-to-consumer (DTC) digital navigator platform for individuals at risk for HIV. At Gilead, Mr. Reddi also held various strategy and operations roles of increasing responsibility in international access, medical affairs, international operations, corporate affairs, corporate strategy, global commercial product strategy and in the chief patient officer organization focused on patient centricity, digital patient solutions and patient centered outcomes. He was instrumental in establishing international access and emerging markets initiatives in over 140 countries for the HIV medicines Truvada®, Descovy®, Genvoya® and Biktarvy® and the hepatitis C treatments Sovaldi®, Harvoni®, Epclusa® and Vosevi® resulting in over 18 million patients with access to these treatments in resource limited settings.
Prior to Gilead, Mr. Reddi was active in basic science, clinical research and global health policy with over 20 peer reviewed publications. His basic science research focused on skin cancer metastasis and signal transduction as well as bone tissue engineering. His clinical research and public health interests focused on global HIV/AIDS. His writings on global health have appeared in scientific journals such as Science, JAMA Pediatrics, AIDS, and JAIDS as well as in the opinion pages of The Huffington Post (as a featured contributor), The Washington Post and The New York Times.
Mr. Reddi was a Doctor of Medicine candidate and holds a Master of Science from the University of Colorado School of Medicine. He received a Bachelor of Arts in history and a Bachelor of Science in biology from the University of Michigan, Ann Arbor. In addition, Mr. Reddi has the distinction of serving as a J. William Fulbright Scholar in South Africa. Mr. Reddi also served as vice-chair on the board of directors of the Bay Area Global Health Alliance and past member of the board of directors of the AIDS Healthcare Foundation. In 2016, he was an Atlantic Dialogues Emerging Leader.
Wally Kuhns is a seasoned Human Resources executive with global operating experience across several industries (med tech, consumer products, automation & controls, industrial chemicals, and service). Most recently, Wally served as VP, Human Resources for Dexcom, Inc. (San Diego, CA) where he led a team of 50+ HR employees based in the Americas, EMEA, and APAC. In October 2021, Wally relaunched his consulting practice, WKleadersolutions.com.